Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001762572-26-000006

Chief Patient Officer sold 3,712 shares at an average $32.14 ($119,311)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hoitt Jason Chief Patient Officer 2026-03-17 Sale −1,033 $32.74 $33,820 12,955 D: show line 1 in the form
Hoitt Jason Chief Patient Officer 2026-03-17 Sale −748 $33.38 $24,965 12,207 D: show line 2 in the form
Hoitt Jason Chief Patient Officer 2026-03-18 Sale −1,762 $31.28 $55,122 10,445 D: show line 3 in the form
Hoitt Jason Chief Patient Officer 2026-03-18 Sale −139 $31.79 $4,419 10,306 D: show line 4 in the form
Hoitt Jason Chief Patient Officer 2026-03-18 Sale −30 $32.85 $986 10,276 D: show line 5 in the form
Open-market sales · 3,712 sh · avg $32.14 · $119,311
Loading xslF345X06/form4-03192026_090337.xml…